Nutriband Inc. (NASDAQ:NTRBW – Get Free Report)’s stock price traded down 8.1% during mid-day trading on Thursday . The company traded as low as $1.41 and last traded at $1.47. 738 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 7,096 shares. The stock had previously closed at $1.60.
Nutriband Stock Performance
The company’s 50-day simple moving average is $1.51 and its 200 day simple moving average is $1.31.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Read More
- Five stocks we like better than Nutriband
- What Are Dividend Champions? How to Invest in the Champions
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- P/E Ratio Calculation: How to Assess Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Following Congress Stock Trades
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
